Table 1. Clinical presentation of patients
No. Sex Age, y FAB Karyotype WBC, G/I % blasts in PBLs LDH, units/ml
1 M 52 M1 46;XY;t(3;21) 22.2 78 954
2 F 60 M1 45;XX;t(3;21);−7 14.3 54 752
3 M 68 M2 46;XY;t(3;21) 13.2 58 674
4 M 48 M1 46;XY;t(3;21) 38.4 95 1,455
5 F 58 M1 46;XX;t(3;21) 55.8 98 1,025
6 F 64 M2 46;XX;t(3;21) 18.2 45 770
7 M 56 M4 46;XY;t(3;21);inv(1)(q25q44) 8.2 25 482
8 M 59 M2 46;XY;t(3;21);+8 15.3 38 920
9 F 72 M1 46;XX;t(3;21) 32.8 90 1,285
10 M 44 M4 46;XY 6.6 30 380
11 M 54 M2 46;XY 24.5 85 842
12 M 58 M4 46;XY 14.4 55 710
13 M 58 M4 46;XY 98.8 98 1,662
14 F 74 M4 46;XX 30.5 72 908
15 M 62 M4 46;XY 84.5 98 1,585
16 F 61 M4 46;XX 18.8 65 880
17 M 56 M2 46;XY 21.5 55 560
18 F 70 M1 46;XX 19.5 72 980
19 F 52 M1 46;XX 52.2 92 1,440
  • M, male; F, female; FAB, French-American-British classification; WBC, white blood cell count; PBL, peripheral blood leukocytes; LDH, lactate dehydrogenase; G/l: 109 per liter.